drugset / Trial / NCT06739759

Ovarian Hyperstimulation Syndrome Prevention

NCT06739759

Recruiting 300 enrolled Aljazeera Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

Ovarian hyperstimulation is a very hazardous complication of ICSI

Timeline

Start
2024-11-17
Primary completion
2025-06-30
Completion
2025-07-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Decapeptyl Unknown
Comparator Hydroxychloroquine Small molecule